Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
La Revue Du Praticien|September 5, 2006
[Drug therapy in multiple sclerosis]Emmanuelle Le Page, Gilles EdanJournal of the Neurological Sciences|February 10, 2009
Long-term experience with induction treatment regimens in multiple sclerosisEmmanuelle Le Page, Gilles EdanDrugs|September 19, 2023
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?Gilles Edan, Emmanuelle Le PageCNS Drugs|May 10, 2013
Induction therapy for patients with multiple sclerosis: why? When? How?Gilles Edan, Emmanuelle Le PageJournal of the Neurological Sciences|July 21, 2004
Rationale for the use of mitoxantrone in multiple sclerosisGilles Edan, Sean Morrissey, Emmanuelle Le PageClinica Chimica Acta; International Journal of Clinical Chemistry|November 25, 2006
Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assayCatherine Massart, Jacqueline Gibassier, Joël Oger, et al.Journal of Neurology|February 22, 2015
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational studyEmmanuelle Le Page, Véronique Deburghgraeve, Marie-Antoinette Lester, et al.Brain : a Journal of Neurology|April 29, 2010
Evidence for a two-stage disability progression in multiple sclerosisEmmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2007
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patientsEmmanuelle Le Page, Emmanuelle Leray, Grégory Taurin, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosisKevin Ahrweiller, Chloé Rousseau, Emmanuelle Le Page, et al.Pageof 19